Zedonac MR 250mg/50mg/500mg Tablet is a combination medication containing Chlorzoxazone 250mg, Diclofenac 50mg, and Paracetamol 500mg, formulated for the management of musculoskeletal pain and inflammation. Chlorzoxazone acts as a centrally acting muscle relaxant, alleviating muscle spasms and associated discomfort. Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), provides potent analgesic and anti-inflammatory effects by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Paracetamol contributes additional analgesic and antipyretic properties, enhancing overall pain relief while minimizing inflammation. This multi-component tablet is indicated for conditions such as acute musculoskeletal injuries, strains, sprains, and other painful musculoskeletal disorders where muscle spasm and inflammation coexist. The modified-release formulation ensures sustained therapeutic plasma levels, improving patient compliance and symptom control. Zedonac MR should be used under medical supervision, considering contraindications such as hypersensitivity to any component, active gastrointestinal bleeding, severe hepatic or renal impairment, and cardiovascular risks associated with NSAIDs. Caution is advised in patients with a history of peptic ulcers, asthma, or bleeding disorders. Common adverse effects may include gastrointestinal discomfort, dizziness, and allergic reactions. Regular monitoring is recommended during prolonged therapy to ensure safety and efficacy.